Skip to content

Almost three-quarters of people starting HIV therapy in Tanzania have dyslipidemia after three years of treatment

People doing well on HIV therapy "should be eligible" for life insurance cover

Self-testing and home treatment initiation triples uptake of HIV treatment in Malawi

French researchers report 14 patients in 'remission' after controlling HIV for over 4 years off treatment

Gene therapy studies show potential for HIV control without drugs

Patrick Younan, Fred Hutchinson Cancer Res Ctr, Seattle, presenting at CROI 2013.

Malawi achieves seven-fold increase in ART for pregnant and breastfeeding women

New integrase inhibitor dolutegravir helps treatment-experienced people on failing therapy

Second-line NRTI-sparing regimen proves equally effective for resource-limited settings

Can people with resistant HIV omit NRTIs when switching from a failing regimen?

Karen Tashima, Brown University, presenting at CROI 2013. © Liz Highleyman / hivandhepatitis.com